Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
Study Identifier:
C07-001
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Eculizumab
Date
Nov 2007 - Jun 2008
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 12+ years
Requirements Information
Sex
Female & Male
Age
12+ years
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Eculizumab
Date
Nov 2007 - Jun 2008
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 12+ years years
Requirements Information
Protocol Summary
A study to assess the safety and efficacy of eculizumab in Japanese patients with hemolytic PNH.
Trial Locations
No locations found.